Annual Drug Patent Expirations for PEDMARK
Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has thirty-six patent family members in thirteen countries.
The generic ingredient in PEDMARK is sodium thiosulfate. One supplier is listed for this compound. Additional details are available on the sodium thiosulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
